These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 35085659)

  • 1. Disease severity during SARS-COV-2 reinfection: a nationwide study.
    Mensah AA; Lacy J; Stowe J; Seghezzo G; Sachdeva R; Simmons R; Bukasa A; O'Boyle S; Andrews N; Ramsay M; Campbell H; Brown K
    J Infect; 2022 Apr; 84(4):542-550. PubMed ID: 35085659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection of hybrid immunity against SARS-CoV-2 reinfection and severe COVID-19 during periods of Omicron variant predominance in Mexico.
    Montes-González JA; Zaragoza-Jiménez CA; Antonio-Villa NE; Fermín-Martínez CA; Ramírez-García D; Vargas-Vázquez A; Gutiérrez-Vargas RI; García-Rodríguez G; López-Gatell H; Valdés-Ferrer SI; Bello-Chavolla OY
    Front Public Health; 2023; 11():1146059. PubMed ID: 37081954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of SARS-CoV-2 reinfections in children: a prospective national surveillance study between January, 2020, and July, 2021, in England.
    Mensah AA; Campbell H; Stowe J; Seghezzo G; Simmons R; Lacy J; Bukasa A; O'Boyle S; Ramsay ME; Brown K; Ladhani SN
    Lancet Child Adolesc Health; 2022 Jun; 6(6):384-392. PubMed ID: 35358491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of SARS-CoV-2 reinfection and COVID-19 hospitalisation in individuals with natural and hybrid immunity: a retrospective, total population cohort study in Sweden.
    Nordström P; Ballin M; Nordström A
    Lancet Infect Dis; 2022 Jun; 22(6):781-790. PubMed ID: 35366962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effect of a first SARS-CoV-2 infection from reinfection: a matched retrospective cohort study using PCR testing data in England.
    Lacy J; Mensah A; Simmons R; Andrews N; Siddiqui MR; Bukasa A; O'Boyle S; Campbell H; Brown K
    Epidemiol Infect; 2022 May; 150():e109. PubMed ID: 35607808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 Reinfection Rate and Outcomes in Saudi Arabia: A National Retrospective Study.
    Al-Otaiby M; Krissaane I; Al Seraihi A; Alshenaifi J; Qahtani MH; Aljeri T; Zaatari E; Hassanain M; Algwizani A; Albarrag A; Al-Mozaini M; Alabdulaali M
    Int J Infect Dis; 2022 Sep; 122():758-766. PubMed ID: 35840098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness Associated With Vaccination After COVID-19 Recovery in Preventing Reinfection.
    Lewis N; Chambers LC; Chu HT; Fortnam T; De Vito R; Gargano LM; Chan PA; McDonald J; Hogan JW
    JAMA Netw Open; 2022 Jul; 5(7):e2223917. PubMed ID: 35895058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Incidence of SARS-CoV-2 Reinfection in Persons With Naturally Acquired Immunity With and Without Subsequent Receipt of a Single Dose of BNT162b2 Vaccine : A Retrospective Cohort Study.
    Gazit S; Shlezinger R; Perez G; Lotan R; Peretz A; Ben-Tov A; Herzel E; Alapi H; Cohen D; Muhsen K; Chodick G; Patalon T
    Ann Intern Med; 2022 May; 175(5):674-681. PubMed ID: 35157493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency and risk of SARS-CoV-2 reinfections in Norway: a nation-wide study, February 2020 to January 2022.
    Bøås H; Storm ML; Tapia G; Kristoffersen AB; Løvlie AL; Størdal K; Lyngstad TM; Bragstad K; Hungnes O; Veneti L
    BMC Public Health; 2024 Jan; 24(1):181. PubMed ID: 38225588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molnupiravir and risk of post-acute sequelae of covid-19: cohort study.
    Xie Y; Choi T; Al-Aly Z
    BMJ; 2023 Apr; 381():e074572. PubMed ID: 37161995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence, Risk, and Severity of SARS-CoV-2 Reinfections in Children and Adolescents Between March 2020 and July 2022 in Serbia.
    Medic S; Anastassopoulou C; Lozanov-Crvenkovic Z; Dragnic N; Petrovic V; Ristic M; Pustahija T; Tsakris A; Ioannidis JPA
    JAMA Netw Open; 2023 Feb; 6(2):e2255779. PubMed ID: 36780157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 reinfections in a US university setting, Fall 2020 to Spring 2021.
    Rosenberg M; Chen C; Golzarri-Arroyo L; Carroll A; Menachemi N; Ludema C
    BMC Infect Dis; 2022 Jul; 22(1):592. PubMed ID: 35787250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and severity of SARS-CoV-2 reinfection, a multicenter cohort study in Shanghai, China.
    Yu W; Guo Y; Hu T; Liu Y; Fan Q; Guo L; Zheng B; Kong Y; Zhu H; Yu J; Chen S; Zhang Y; Wang J; Li F; Yang F; Wang Y; Zhu Y; Huang Y; Shen Z; Ruan Y; Mao R; Zhang J
    J Med Virol; 2023 Aug; 95(8):e28997. PubMed ID: 37537950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reinfection with new variants of SARS-CoV-2 after natural infection: a prospective observational cohort in 13 care homes in England.
    Jeffery-Smith A; Rowland TAJ; Patel M; Whitaker H; Iyanger N; Williams SV; Giddings R; Thompson L; Zavala M; Aiano F; Ellis J; Lackenby A; Höschler K; Brown K; Ramsay ME; Gopal R; Chow JY; Ladhani SN; Zambon M
    Lancet Healthy Longev; 2021 Dec; 2(12):e811-e819. PubMed ID: 34873592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reinfection with SARS-CoV-2 in general population, South Korea; nationwide retrospective cohort study.
    Jang EJ; Choe YJ; Yun GW; Wang S; Cho UJ; Yi S; Lee S; Park YJ
    J Med Virol; 2022 Nov; 94(11):5589-5592. PubMed ID: 35879105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk and severity of SARS-CoV-2 reinfections during 2020-2022 in Vojvodina, Serbia: A population-level observational study.
    Medić S; Anastassopoulou C; Lozanov-Crvenković Z; Vuković V; Dragnić N; Petrović V; Ristić M; Pustahija T; Gojković Z; Tsakris A; Ioannidis JPA
    Lancet Reg Health Eur; 2022 Sep; 20():100453. PubMed ID: 35791336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B.1.1.7: an ecological study.
    Graham MS; Sudre CH; May A; Antonelli M; Murray B; Varsavsky T; Kläser K; Canas LS; Molteni E; Modat M; Drew DA; Nguyen LH; Polidori L; Selvachandran S; Hu C; Capdevila J; ; Hammers A; Chan AT; Wolf J; Spector TD; Steves CJ; Ourselin S
    Lancet Public Health; 2021 May; 6(5):e335-e345. PubMed ID: 33857453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severity and Outcomes of SARS-CoV-2 Reinfection Compared with Primary Infection: A Systematic Review and Meta-Analysis.
    Deng J; Ma Y; Liu Q; Du M; Liu M; Liu J
    Int J Environ Res Public Health; 2023 Feb; 20(4):. PubMed ID: 36834029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rate and severity of suspected SARS-Cov-2 reinfection in a cohort of PCR-positive COVID-19 patients.
    Slezak J; Bruxvoort K; Fischer H; Broder B; Ackerson B; Tartof S
    Clin Microbiol Infect; 2021 Dec; 27(12):1860.e7-1860.e10. PubMed ID: 34419576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of severe symptomatic laboratory-confirmed SARS-CoV-2 reinfection.
    Murillo-Zamora E; Mendoza-Cano O; Delgado-Enciso I; Hernandez-Suarez CM
    Public Health; 2021 Apr; 193():113-115. PubMed ID: 33774512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.